A detailed history of Pier 88 Investment Partners LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 236,900 shares of ABCL stock, worth $596,988. This represents 0.92% of its overall portfolio holdings.

Number of Shares
236,900
Previous 195,500 21.18%
Holding current value
$596,988
Previous $506,000 37.15%
% of portfolio
0.92%
Previous 0.67%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$2.48 - $3.15 $102,672 - $130,410
41,400 Added 21.18%
236,900 $694,000
Q3 2024

Nov 05, 2024

BUY
$2.39 - $3.49 $80,973 - $118,241
33,880 Added 20.96%
195,500 $506,000
Q2 2024

Aug 06, 2024

BUY
$2.73 - $4.73 $345,727 - $599,007
126,640 Added 362.04%
161,620 $478,000
Q1 2024

May 10, 2024

BUY
$4.29 - $5.97 $150,064 - $208,830
34,980 New
34,980 $158,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $719M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.